ESDR073 - Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform

Catherine Smith

The OpenSAFELY Collaborative

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com